RankingsPricing
  1. US-listed companies
  2. AbbVie Inc.
  3. Financials
  4. Retained earnings

AbbVie Inc.ABBV

Market cap
$405.4B
P/E ratio
SummaryFinancials
Period EndRetained earnings (Million USD)YoY (%)
Dec 31, 2024-7,900+690.00%
Dec 31, 2023-1,000-120.90%
Dec 31, 20224,784+52.99%
Dec 31, 20213,127+196.40%
Dec 31, 20201,055-77.63%
Dec 31, 20194,717+40.05%
Dec 31, 20183,368-38.30%
Dec 31, 20175,459+24.69%
Dec 31, 20164,378+94.75%
Dec 31, 20152,248+320.19%
Dec 31, 2014535-65.86%
Dec 31, 20131,567

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)